Compare CHEF & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CHEF | PLSE |
|---|---|---|
| Founded | 1985 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Distributors | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 3.6B |
| IPO Year | 2011 | 2015 |
| Metric | CHEF | PLSE |
|---|---|---|
| Price | $112.51 | $49.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 6 |
| Target Price | ★ $120.33 | $54.00 |
| AVG Volume (30 Days) | 500.0K | ★ 570.3K |
| Earning Date | 10-28-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 27.27 | N/A |
| EPS | ★ 0.40 | N/A |
| Revenue | ★ $1,301,520,000.00 | N/A |
| Revenue This Year | $10.47 | $477.71 |
| Revenue Next Year | $8.59 | $233.00 |
| P/E Ratio | $279.23 | ★ N/A |
| Revenue Growth | ★ 9.11 | N/A |
| 52 Week Low | $53.24 | $12.56 |
| 52 Week High | $117.65 | $58.90 |
| Indicator | CHEF | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 52.93 | 49.99 |
| Support Level | $105.45 | $49.01 |
| Resistance Level | $116.31 | $57.82 |
| Average True Range (ATR) | 3.50 | 3.21 |
| MACD | -0.00 | -0.80 |
| Stochastic Oscillator | 64.28 | 16.43 |
The Chefs' Warehouse Inc is a specialty food distributor in metropolitan areas across the United States, the Middle East and Canada. The company's product portfolio is comprised of imported and local specialty food products such as cheese, cooking oils, chocolates, dried food, baking products, meats, and other food products. It operates via one reporting segment called Food Product Distribution. Operations are concentrated on the east, midwest, and west coasts of the U.S. The company provides service to restaurants, clubs, hotels, caterers, schools, bakeries, casinos, and specialty food stores.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.